Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Vascular Solutions Inc (NASDAQ: VASC) acted responsibly on behalf of investors’ profitability in the planned $1.0 billion sale to Teleflex Incorporated (NYSE: TFX).

On December 2, 2016, Vascular Solutions Inc (NASDAQ: VASC) and Teleflex Incorporated (NYSE: TFX) announced that they had entered into a merger agreement. Under the terms of the merger agreement, Teleflex will offer Vascular shareholders $56.00 per share in cash for all outstanding shares.    

Based in Minneapolis, Minnesota, and founded in 1996 Vascular Solutions Inc provides clinical solutions for treating coronary and peripheral vascular disease.

The investigation is looking to uncover whether Vascular Solutions Inc was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $58.00 per share.

If you purchased Vascular Solutions Inc (NASDAQ: VASC) prior to December 2, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185